Sarissa Capital Management’s Gilead Sciences GILD Stock Holding History

Sarissa Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-262,080	Closed	-$24.2M	–	8
2024 Q4	$24.2M	Sell	262,080 -501,253	-66%	-$45.1M	7.5%	5
2024 Q3	$64M	Sell	763,333 -339,949	-31%	-$25.9M	15.91%	3
2024 Q2	$75.7M	Hold	1,103,282	–	–	12.78%	4
2024 Q1	$80.8M	Buy	1,103,282 +27,882	+3%	+$2.14M	14.14%	4
2023 Q4	$87.1M	Buy	1,075,400 +155,000	+17%	+$12.1M	13.43%	4
2023 Q3	$69M	Hold	920,400	–	–	9.29%	5
2023 Q2	$70.9M	Buy	920,400 +70,400	+8%	+$5.61M	7.06%	5
2023 Q1	$70.5M	Sell	850,000 -218,750	-20%	-$18.1M	9.02%	5
2022 Q4	$91.8M	Sell	1,068,750 -204,350	-16%	-$16.2M	10.92%	4
2022 Q3	$78.5M	Sell	1,273,100 -68,800	-5%	-$4.34M	8.88%	4
2022 Q2	$82.9M	Sell	1,341,900 -221,000	-14%	-$13.7M	8.35%	5
2022 Q1	$92.9M	Sell	1,562,900 -1,326,400	-46%	-$84.8M	8.78%	5
2021 Q4	$210M	Sell	2,889,300 -78,000	-3%	-$5.37M	18.16%	2
2021 Q3	$207M	Buy	2,967,300 +269,900	+10%	+$19M	16.27%	3
2021 Q2	$186M	Hold	2,697,400	–	–	14.77%	4
2021 Q1	$174M	Buy	+2,697,400	New	+$174M	16.71%	3

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Sarissa Capital Management's GILD Position: Q1 2025 in Review

Sarissa Capital Management sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 262,080 shares — an estimated $24.2M sold.

Sarissa Capital Management first reported a position in GILD in Q1 2021 and held it in 16 quarters. The position peaked at $210M in Q4 2021. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

Sarissa Capital Management reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
Sarissa Capital Management sold 262,080 Gilead Sciences shares in Q1 2025, an estimated $24.2M.
Sarissa Capital Management first reported a position in Gilead Sciences in Q1 2021 and held it in 16 quarters.
Sarissa Capital Management's Gilead Sciences position peaked at $210M in Q4 2021.
2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Sarissa Capital Management's 13F filing for Q1 2025, filed 15 May 2025.